Empagliflozin Associated With Lower EAT Thickness in T2DM Tags Echocardiography hBA1c SGLT-2 Inhibitor Read more about Empagliflozin Associated With Lower EAT Thickness in T2DM
Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Downstream Medication Use Differs After GLP-1 vs SGLT2 Start in T2DM
Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM Tags GLP-1 agonists SGLT-2 Inhibitor Read more about Combination Therapy Tied to Reduced Colon Cancer Risk in T2DM
SGLT2 Inhibitor Use Linked to Higher Knee Replacement Risk Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use Linked to Higher Knee Replacement Risk
No Higher Amputation Risk Seen With SGLT2 Inhibitors in DFU Tags Peripheral vascular disease Diabetic foot. SGLT-2 Inhibitor Read more about No Higher Amputation Risk Seen With SGLT2 Inhibitors in DFU
DKA Risk Similar Across Kidney Function Levels in Type 1 Diabetes Tags Diabetic ketoacidosis SGLT-2 Inhibitor Read more about DKA Risk Similar Across Kidney Function Levels in Type 1 Diabetes
Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors Tags GLP-1 agonists DPP-4 inhibitors SGLT-2 Inhibitor Read more about Gout Medication Use Lower Among T2DM Patients Using SGLT2 Inhibitors
Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD Tags Coronary artery disease SGLT-2 Inhibitor Read more about Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD
GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM Tags Coronary artery disease Stroke GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM
Recurrent Ischemic Stroke Lower With SGLT2i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Stroke Read more about Recurrent Ischemic Stroke Lower With SGLT2i in T2DM